| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer (NCT06331988) | European Institute of Oncology | 2022-07-21 |
| The Effect of a Mobile Application on Patient Outcomes in Colorectal Cancer Patients (NCT05813028) | Ankara University | 2022-07-15 |
| Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities (NCT05404230) | Vejle Hospital | 2022-07-15 |
| PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor (NCT05803746) | Peking University Cancer Hospital & Institute | 2022-07-15 |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) (NCT05432193) | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 2022-07-13 |
| The Effect of Oral Carbohydrate Administration on Postoperative Well-being (NCT05402592) | Muğla Sıtkı Koçman University | 2022-07-13 |
| FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma (NCT05209750) | The Netherlands Cancer Institute | 2022-07-13 |
| Patient Outcomes After Hepatic Artery Infusion Pump Placement (NCT05468593) | Mayo Clinic | 2022-07-12 |
| Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy (NCT05435313) | Fudan University | 2022-07-12 |
| A Prospective Cohort Study on Colorectal Cancer Screening in Community Population (NCT05485077) | Singlera Genomics Inc. | 2022-07-09 |
| Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. (NCT06321640) | European Institute of Oncology | 2022-07-08 |
| Project CADENCE (CAncer Detected Early caN be CurEd) (NCT05633342) | MiRXES Pte Ltd | 2022-07-07 |
| Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer (NCT05663788) | Althaia Xarxa Assistencial Universitària de Manresa | 2022-07-01 |
| ARGONAUT: Stool and Blood Sample Bank for Cancer Patients (NCT04638751) | Persephone Biosciences | 2022-07-01 |
| The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study (NCT05402124) | University of Calgary | 2022-07-01 |
| Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy (NCT05451719) | Fudan University | 2022-07-01 |
| The Argentina Brief Colonoscopy Difficulty Score (ABCD) (NCT05422820) | Institute of Gastroenterology and Advance Endoscopy | 2022-07-01 |
| Microbiome in Colorectal Cancer Onset and Progression (NCT05368688) | Viome | 2022-06-30 |
| Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia (NCT05405673) | Chinese University of Hong Kong | 2022-06-29 |
| Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) (NCT05382364) | Pfizer | 2022-06-29 |
| Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection (NCT05517811) | University of Colorado, Denver | 2022-06-26 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors (NCT05256381) | SOTIO Biotech AG | 2022-06-21 |
| Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays (NCT05234177) | Tempus AI | 2022-06-21 |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849) | TCR2 Therapeutics | 2022-06-21 |
| Increasing Uptake of Bowel Screening (NCT05408169) | University of Glasgow | 2022-06-20 |
| Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer (NCT05444491) | Singlera Genomics Inc. | 2022-06-20 |
| Colonoscopy Outreach for Rural Communities Aim 2 (NCT05453630) | University of Washington | 2022-06-16 |
| Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer (NCT06561516) | Gangnam Severance Hospital | 2022-06-14 |
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680) | Cue Biopharma | 2022-06-14 |
| A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study (NCT05600309) | Merck Sharp & Dohme LLC | 2022-06-14 |
| A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours (NCT05397171) | AstraZeneca | 2022-06-07 |
| TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy (NCT05343013) | M.D. Anderson Cancer Center | 2022-06-06 |
| ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension (NCT05056896) | Massachusetts General Hospital | 2022-06-03 |
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy (NCT06414304) | OncoAtlas LLC | 2022-06-01 |
| Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs. (NCT04967183) | Fundacin Biomedica Galicia Sur | 2022-06-01 |
| Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer (NCT06172647) | Hospital Mutua de Terrassa | 2022-06-01 |
| Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study (NCT07346534) | Shanghai 10th People's Hospital | 2022-06-01 |
| Appendectomy and Colorectal Cancer (NCT06091137) | Chinese University of Hong Kong | 2022-06-01 |
| Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients (NCT05369312) | Betta Pharmaceuticals Co., Ltd. | 2022-06-01 |
| Early Discharge After Robotic Colorectal Surgery (eRCS): a Prospective Observational Study (NCT05408182) | Ospedale di Camposampiero | 2022-06-01 |
| Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases (NCT05353582) | Sun Yat-sen University | 2022-06-01 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| Mailed FIT Outreach 2022 (NCT05341622) | Abramson Cancer Center at Penn Medicine | 2022-05-27 |
| A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors (NCT05396300) | Weijia Fang, MD | 2022-05-25 |
| The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients (NCT05246943) | The University of Texas Medical Branch, Galveston | 2022-05-25 |
| Effect of Exercise on Bowel Function in Colorectal Cancer Survivors (NCT05420870) | Yonsei University | 2022-05-23 |
| Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping (NCT06048458) | University College, London | 2022-05-18 |
| Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results? (NCT05329870) | University of Edinburgh | 2022-05-18 |
| Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers (NCT05114798) | University of Illinois at Chicago | 2022-05-17 |
| Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life (NCT05242562) | Radboud University Medical Center | 2022-05-16 |
| Supervised Exercise for Post-surgery Colorectal Cancer Patients (NCT05090215) | University of Nottingham | 2022-05-13 |
| Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention (NCT05338307) | Abramson Cancer Center at Penn Medicine | 2022-05-13 |
| Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages (NCT05445570) | Venn Biosciences Corporation | 2022-05-13 |
| It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is Limited (NCT05336617) | Centre Hospitalier Sud Francilien | 2022-05-13 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer (NCT05371197) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-05-05 |
| Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial (NCT05609396) | Dublin City University | 2022-05-03 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829) | Day One Biopharmaceuticals, Inc. | 2022-05-02 |
| Colorectal Cancer Screening Based on Predicted Risk (NCT05357508) | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | 2022-05-01 |
| The Diverticulitis Study (NCT06023004) | University of Aarhus | 2022-05-01 |
| Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence (NCT05587452) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-05-01 |
| Study on the Diagnostic Value of Multi-omics Combined Detection for Precancerous Lesions of CRC (NCT05530746) | Changhai Hospital | 2022-05-01 |
| Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial (NCT05411783) | San Carlo di Nancy Hospital | 2022-05-01 |
| A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer (NCT05544812) | Xijing Hospital | 2022-05-01 |
| An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC) (NCT05340231) | Gang Wu | 2022-05-01 |
| Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC (NCT06002789) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-05-01 |
| Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance (NCT05528783) | Sun Yat-sen University | 2022-04-25 |
| Hand-Foot Exercises for Chemotheraphy Induced Peripheral Neuropathy Pain, Falls and Quality of Life in Colorectal Cancer (NCT05873829) | Gulhane Training and Research Hospital | 2022-04-25 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| Prognostic Value of Effort-independent Cardiopulmonary Exercise Test Variables for Postoperative Complications After Elective Colorectal Surgery (NCT05331196) | VieCuri Medical Centre | 2022-04-15 |
| Association Between New Effort-independent Cardiopulmonary Exercise Test Variables and Postoperative Complications After Elective Colorectal Surgery (NCT05483179) | VieCuri Medical Centre | 2022-04-15 |
| Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation (NCT05288205) | Allist Pharmaceuticals, Inc. | 2022-04-14 |
| Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment (NCT05353127) | VieCuri Medical Centre | 2022-04-12 |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735) | Alaunos Therapeutics | 2022-04-04 |
| TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer (NCT05314101) | Fujian Cancer Hospital | 2022-04-01 |
| Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer (NCT05327751) | Tanta University | 2022-04-01 |
| A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou (NCT05336539) | Singlera Genomics Inc. | 2022-04-01 |
| Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis (NCT06884839) | Minia University | 2022-04-01 |
| Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients (NCT07320950) | Sun Yat-sen University | 2022-04-01 |
| Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer (NCT06428487) | Blokhin's Russian Cancer Research Center | 2022-03-31 |
| A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys (NCT04990895) | AHS Cancer Control Alberta | 2022-03-30 |
| Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP) (NCT05383976) | Abramson Cancer Center at Penn Medicine | 2022-03-29 |
| Retrospective Analysis of Colorectal Cancer Screening Results (NCT05374369) | Creative Biosciences (Guangzhou) Co., Ltd. | 2022-03-29 |
| Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling (NCT05646030) | Erasmus Medical Center | 2022-03-25 |
| Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (NCT04257526) | International Agency for Research on Cancer | 2022-03-23 |
| Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis (NCT05346757) | Fundacion Clinic per a la Recerca Biomédica | 2022-03-23 |
| Connecting Audio and Radio Sensing Systems to Improve Care at Home (NCT05344950) | UNC Lineberger Comprehensive Cancer Center | 2022-03-21 |
| Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer (NCT06783985) | Sir Run Run Shaw Hospital | 2022-03-16 |
| Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot) (NCT05273931) | Centre Leon Berard | 2022-03-16 |
| Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients. (NCT05221957) | Zealand University Hospital | 2022-03-01 |
| Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy. (NCT05240625) | National Taiwan University Hospital | 2022-03-01 |
| Comparison of Method for Skin Closure in Colorectal Cancer. (NCT06549803) | Yoon Suk Lee | 2022-03-01 |
| Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients (NCT04728139) | Assiut University | 2022-03-01 |
| Preoperative 3D Models and Shared Decision-making (NCT06625008) | Vanderbilt University Medical Center | 2022-03-01 |
| Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer (NCT05220800) | Zealand University Hospital | 2022-03-01 |
| Single cEll pRofiling PErsistaNce To ImmuNothErapy (NCT06680739) | Vall d'Hebron Institute of Oncology | 2022-03-01 |